Type I Neurofibromatosis
1 clinical trials · Condition
◉ Watch Type I Neurofibromatosis
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis (NCT05107037) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-11-01 |
Track Type I Neurofibromatosis automatically
Every clearance here is in the API, with alerts when new ones post.